Diagnos Inc.
DGNOF
$0.16
$0.002.17%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.67% | -0.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.67% | -0.91% | |||
| Cost of Revenue | -371.36% | 9.72% | |||
| Gross Profit | 385.54% | -10.16% | |||
| SG&A Expenses | 18.34% | 1.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.82% | 4.28% | |||
| Operating Income | -6.87% | -4.35% | |||
| Income Before Tax | -2.26% | -4.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.26% | -4.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.26% | -4.64% | |||
| EBIT | -6.87% | -4.35% | |||
| EBITDA | -6.93% | -7.63% | |||
| EPS Basic | -9.86% | 8.97% | |||
| Normalized Basic EPS | -11.36% | 10.20% | |||
| EPS Diluted | -9.86% | 8.97% | |||
| Normalized Diluted EPS | -11.36% | 10.20% | |||
| Average Basic Shares Outstanding | -6.99% | 14.81% | |||
| Average Diluted Shares Outstanding | -6.99% | 14.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||